LifeMD, Inc.
LFMD
$8.26
$0.101.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.25% | 20.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.25% | 20.34% | |||
| Cost of Revenue | -8.34% | 88.09% | |||
| Gross Profit | 4.07% | 13.32% | |||
| SG&A Expenses | 1.39% | 0.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -10.33% | 28.69% | |||
| Total Operating Expenses | -0.13% | 8.88% | |||
| Operating Income | 149.74% | 121.73% | |||
| Income Before Tax | 374.17% | 107.71% | |||
| Income Tax Expenses | -- | -27.10% | |||
| Earnings from Continuing Operations | 716.62% | 104.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -55.95% | -198.61% | |||
| Net Income | 1,402.73% | 97.93% | |||
| EBIT | 149.74% | 121.73% | |||
| EBITDA | 106.42% | 133.32% | |||
| EPS Basic | 167.46% | 85.14% | |||
| Normalized Basic EPS | 833.33% | 96.99% | |||
| EPS Diluted | 147.85% | 85.14% | |||
| Normalized Diluted EPS | 795.24% | 96.99% | |||
| Average Basic Shares Outstanding | 2.20% | 0.44% | |||
| Average Diluted Shares Outstanding | 8.00% | 0.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.08% | -47.29% | |||